2020年9月10-12日，由浙江省藥學(xué)會(huì)生物制藥專業(yè)委員會(huì)、浙江省海高會(huì)生物醫(yī)藥分會(huì)和生物制藥穩(wěn)定性論壇公眾號(hào)共同主辦的“2020生物制藥穩(wěn)定性論壇---助力生物藥研發(fā)：解決生物制藥研發(fā)和產(chǎn)業(yè)化過(guò)程中極具挑戰(zhàn)的穩(wěn)定性問(wèn)題”在杭州召開。

來(lái)自國(guó)內(nèi)外企業(yè)界、高校、監(jiān)管部門等生物制藥穩(wěn)定性領(lǐng)域的知名專家、學(xué)者到會(huì)，進(jìn)行了精彩的主題報(bào)告。

MFI作為ProteinSimple用于藥物制劑優(yōu)化開發(fā)中檢測(cè)不溶性顆粒以及顆粒物形態(tài)分析的技術(shù)，備受客戶推崇。

ProteinSimple作為ling先的生命科學(xué)儀器制造商和技術(shù)提供商，參加了本次盛會(huì)。

ProteinSimple大中華區(qū)應(yīng)用技術(shù)經(jīng)理杜穎穎博士在會(huì)上做了精彩報(bào)告：“生物藥穩(wěn)定性表征整體解決方案”。

PPT分享如下：

2020年10月24-25日，由生物制品圈、抗體圈共同主辦的第三屆抗體藥產(chǎn)業(yè)發(fā)展大會(huì)在上海召開。

來(lái)自國(guó)內(nèi)外著名抗體藥物企業(yè)家、權(quán)威專家、知名學(xué)者、科技精英，行業(yè)協(xié)會(huì)和組織代表等共赴此次盛會(huì)，共同交流生物制藥前沿技術(shù)和經(jīng)驗(yàn)，探討行業(yè)發(fā)展趨勢(shì)。

ProteinSimple作為ling先的生命科學(xué)儀器制造商和技術(shù)提供商，參加了本次盛會(huì)。

ProteinSimple市場(chǎng)部蘇倩博士在會(huì)上做了精彩報(bào)告：“生物大分子藥物質(zhì)量控制的創(chuàng)新技術(shù)”。

PPT分享如下：

Santa Clara, CA, July 18, 2011 Cell Biosciences, Inc. today announced that it has changed its name to ProteinSimple to clearly reflect the Company's core mission in protein research.

The Company's goal is simply to help researchers gain a better understanding of proteins and their role in disease. ProteinSimple's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins.

Over the past 3 years, ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling. Later this year, the Company will launch a revolutionary product that is expected to completely reinvent and automate the Western Blot the most widely used technique in protein analysis.

The company expects to generate over $40 million in revenue in 2011, and has grown significantly from $1 million in 2008. ProteinSimple has over 170 employees and more than 10,000 systems installed around the world. In the last 18 months, the Company has made 4 acquisitions in the protein analysis space and raised over $60 million in venture capital.

“We are all very excited about our new ProteinSimple identity,” commented Tim Harkness, President and CEO of ProteinSimple. “After a period of tremendous growth and change, we felt it was important to speak clearly to our customers about our vision and goals. ProteinSimple captures our entire value proposition and culture in a single word. The employees of ProteinSimple are fully committed to helping researchers gain a deeper understanding of proteins and to building a unique protein analysis pure-play.”

About ProteinSimple

ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. The Company's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins. ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling. ProteinSimple has over 170 employees, more than 10,000 systems installed around the world and is headquartered in Santa Clara, California. For more information, visit www.proteinsimple.com.